Xvivo Perfusion AB (publ) (XVIPF)

Xvivo Perfusion AB Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,048	1,392	1,032	524	909	1,098
Market Cap Growth	9.04%	34.85%	97.06%	-42.36%	-17.26%	126.84%
Enterprise Value	1,018	1,353	976	494	878	1,025
Last Close Price	32.90	41.10	22.80	20.55	30.97	28.00
PE Ratio	76.76	89.46	113.04	296.26	1007.78	-
PS Ratio	12.30	18.73	17.37	13.15	31.80	50.14
PB Ratio	5.03	7.14	5.34	3.82	6.39	8.94
P/TBV Ratio	7.45	10.81	7.84	6.86	10.06	11.59
P/FCF Ratio	447.18	379.77	3172.09	564.50	-	-
P/OCF Ratio	111.35	138.41	224.23	195.98	-	-
EV/Sales Ratio	11.38	18.21	16.42	12.40	30.71	46.80
EV/EBITDA Ratio	73.58	135.06	515.41	387.15	-	-
EV/EBIT Ratio	100.33	167.53	1818.08	1156.32	-	-
EV/FCF Ratio	434.39	369.29	2998.27	532.54	-	-
Debt / Equity Ratio	0.01	0.02	0.02	0.01	0.00	0.01
Debt / EBITDA Ratio	0.22	0.28	1.06	0.51	-	-
Debt / FCF Ratio	1.25	0.84	9.61	1.03	-	-
Asset Turnover	0.38	0.36	0.30	0.25	0.19	0.20
Inventory Turnover	1.13	1.12	1.23	1.29	1.02	0.97
Quick Ratio	3.59	3.14	4.94	2.60	4.43	5.51
Current Ratio	5.20	4.58	6.15	3.47	5.24	6.41
Return on Equity (ROE)	6.69%	8.39%	5.44%	1.36%	0.71%	-5.51%
Return on Assets (ROA)	2.67%	2.43%	0.17%	0.17%	-0.87%	-3.09%
Return on Capital (ROIC)	2.92%	2.68%	0.20%	0.20%	-1.02%	-3.45%
Return on Capital Employed (ROCE)	4.50%	4.00%	0.30%	0.30%	-	-
Earnings Yield	1.30%	1.12%	0.89%	0.34%	0.10%	-0.48%
FCF Yield	0.22%	0.26%	0.03%	0.18%	-0.27%	-0.17%
Buyback Yield / Dilution	-4.40%	-5.73%	-1.39%	-2.04%	-6.49%	-1.39%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.